A phase 1 multiple ascending dose study of cabozantinib (XL184) monotherapy in Japanese patients with advanced solid tumors

Authors
Category Primary study
JournalMolecular Cancer Therapeutics
Year 2011
This article has no abstract
Epistemonikos ID: 78478a85d21cd21dcf1ebe40acb8ad461710b221
First added on: Feb 04, 2025